NITA CASIMIRO: Open Payments
NPI 1487075198 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 39 payments from 12 companies in 2025. Trend: 2023 $272 · 2024 $366 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 12 | $213 |
| Merck Sharp & Dohme LLC | 5 | $95 |
| ABBVIE INC. | 4 | $67 |
| Aimmune Therapeutics, Inc. | 3 | $57 |
| Cumberland Pharmaceuticals, Inc. | 3 | $51 |
| Novo Nordisk Inc | 3 | $50 |
| Paratek Pharmaceuticals, Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $38 |
| ABIOMED | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $18 |
Products named: CABENUVA, ZERBAXA, VOWST, APRETUDE, VIBATIV, NUZYRA, ZEPBOUND, DOVATO.
Industry payments across NJ — which companies pay providers there.
